Analysts expect Acadia Pharmaceuticals Inc to report revenue of 315.48 M for Q3 26, against a range of 304.69 M to 326.26 M. The most recent reported quarter, Q2 26, came in at 307.96 M, a 7.2% beat against the 287.24 M consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 250.40 M | 259.60 M | 244.32 M | 264.57 M | 278.63 M | 283.99 M | 268.10 M | 307.96 M | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 276.27 M | 259.14 M | 237.89 M | 301.52 M | 313.89 M | 321.60 M | 318.67 M | 314.54 M | 326.26 M | 394.39 M | 359.30 M | 398.46 M | 365.57 M | 400.87 M | 417.34 M | 411.95 M | ||||||||||
| Low Estimate | 232.34 M | 217.03 M | 217.88 M | 250.44 M | 264.76 M | 279.49 M | 269.39 M | 259.95 M | 304.69 M | 365.45 M | 314.55 M | 362.13 M | 336.45 M | 336.02 M | 359.35 M | 345.58 M | ||||||||||
| Consensus Estimate | 254.30 M | 238.08 M | 227.88 M | 275.98 M | 289.32 M | 300.54 M | 294.03 M | 287.24 M | 315.48 M | 379.92 M | 336.93 M | 380.30 M | 351.01 M | 368.45 M | 388.34 M | 378.76 M |
Analysts expect Acadia Pharmaceuticals Inc to report earnings per share of 0.19 for Q3 26, against a range of 0.18 to 0.20. The most recent reported quarter, Q2 26, came in at 0.18, a 157.1% beat against the 0.07 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 0.20 | 0.86 | 0.11 | 0.16 | 0.42 | 1.60 | 0.02 | 0.18 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 0.15 | 0.24 | 0.09 | 0.16 | 0.17 | 0.14 | 0.05 | 0.07 | 0.20 | 0.23 | 0.21 | 0.23 | 0.28 | 0.37 | 0.13 | 0.35 | ||||||||||
| Low Estimate | 0.13 | 0.22 | 0.09 | 0.14 | 0.15 | 0.12 | 0.05 | 0.07 | 0.18 | 0.19 | 0.19 | 0.21 | 0.26 | 0.31 | 0.11 | 0.29 | ||||||||||
| Consensus Estimate | 0.14 | 0.23 | 0.09 | 0.15 | 0.16 | 0.13 | 0.05 | 0.07 | 0.19 | 0.21 | 0.20 | 0.22 | 0.27 | 0.34 | 0.12 | 0.32 |
Pull Wall Street consensus for Acadia Pharmaceuticals Inc (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=ACAD&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "ACAD", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=ACAD&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();